DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $37,657,767 | 14.03% |
Logos Global Management LP | 2,797,501 | $16,141,581 | 2.31% |
Cormorant Asset Management, LP | 5,150,000 | $29,716 | 1.96% |
RA Capital Management | 2,971,231 | $17,144,003 | 0.39% |
Avoro Capital Advisors LLC | 3,500,000 | $20,195,000 | 0.30% |
Rock Springs Capital Management LP | 460,391 | $2,656,456 | 0.06% |
GSA CAPITAL PARTNERS LLP | 97,900 | $565 | 0.06% |
PDT Partners, LLC | 59,969 | $346,021 | 0.05% |
Ergoteles LLC | 177,337 | $1,023,234 | 0.04% |
Atom Investors LP | 11,890 | $68,605 | 0.04% |
Virtus ETF Advisers LLC | 11,396 | $65,755 | 0.04% |
Baker Brothers Advisors | 626,884 | $3,617,121 | 0.02% |
Jump Financial, LLC | 58,800 | $339,276 | 0.01% |
Caption Management, LLC | 86,900 | $501,413 | 0.01% |
HRT FINANCIAL LP | 124,963 | $721 | 0.01% |
Trexquant Investment LP | 50,839 | $293,341 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 12,652 | $73,002 | 0.01% |
ExodusPoint Capital Management, LP | 156,138 | $901 | 0.01% |
Cubist Systematic Strategies, LLC | 178,284 | $1,028,699 | 0.01% |
Citadel Advisors | 2,865,167 | $16,532,014 | 0.00% |
External links
This page lists DESIGN THERAPEUTICS INC's shareholders in Q1 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.